ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)

Technical Analysis Report for NASDAQ stock OTLK Outlook Therapeutics. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics

Outlook Therapeutics Opened at 1.90 and Closed at: 1.81, which is -1.1% of previous session's close. It moved within a range of 1.79 and 1.96
The session was a Bearish session with an average volume of 4315715, which is 34% of previous session's volumes.

  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.

Support for tomorrow is 1.72 and resistance for tomorrow is 1.89
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.75, 1.68 resistance for tomorrow's hourly charts is 1.92, 2.02

10 Day SMA for Outlook Therapeutics (OTLK) is 2.03 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Outlook Therapeutics (OTLK) is 2 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Outlook Therapeutics (OTLK) is 1.67 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 1.56 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Outlook Therapeutics is 1.62 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Outlook Therapeutics is at 2 and 200 DMA is at 1.62, while 50 DMA and 100 DMA are at 1.67 and 1.56 respectively

Outlook Therapeutics (OTLK) moving average of 20 SMA is at 2 and 20 EMA is at 1.94

Outlook Therapeutics (OTLK) moving average of 50 SMA is at 1.67 and 50 EMA is at 1.74

Outlook Therapeutics (OTLK) moving average of 100 SMA is at 1.56 and 100 EMA is at 1.7

Outlook Therapeutics (OTLK) moving average of 200 SMA is at 1.62 and 200 EMA is at 2.1

Trupanion Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Trupanion Inc, about 5.85% more returns!

Outlook Therapeutics has performed better than Strata Skin in short term. Holding Outlook Therapeutics could be a better choice for now!

Outlook Therapeutics has performed better than Sanofi in short term. Holding Outlook Therapeutics could be a better choice for now!

Outlook Therapeutics has performed better than Riot Blockchain in short term. Holding Outlook Therapeutics could be a better choice for now!

Outlook Therapeutics has performed better than Repligen Corporation in short term. Holding Outlook Therapeutics could be a better choice for now!

Ocular Therapeutix has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Ocular Therapeutix, about 2.25% more returns!

Outlook Therapeutics has performed better than Mustang Bio in short term. Holding Outlook Therapeutics could be a better choice for now!

Kezar Life has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Kezar Life, about 1.14% more returns!

Apellis Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Apellis Pharmaceuticals, about 16.11% more returns!

Autolus Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 17.32% more returns!

Capricor Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 453.83% more returns!

Outlook Therapeutics has performed better than Collplant Holdings in short term. Holding Outlook Therapeutics could be a better choice for now!

Outlook Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Outlook Therapeutics could be a better choice for now!

Fortress Biotech has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Fortress Biotech, about 34.97% more returns!

Outlook Therapeutics has performed better than Fulgent Genetics in short term. Holding Outlook Therapeutics could be a better choice for now!

Kodiak Sciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Kodiak Sciences, about 28.95% more returns!

Outlook Therapeutics Technical analysis of indicators

Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Outlook Therapeutics in short term but the sell signal is initial and weak.

Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a buy signal for Outlook Therapeutics in short term but BUY signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Outlook Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.01 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.

Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And OTLK Experts View which covers a lot of information including buying and selling signals

OTLK future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here

Chart Outlook Therapeutics (OTLK)  Technical (Analysis) Reports Outlook Therapeutics [

Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Outlook Therapeutics (OTLK)  Technical (Analysis) Reports Outlook Therapeutics [

 

Back to top